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Human T-cell lymphotropie virus type I (HTLV-I), the causof adult T-cell leukemia, is also associated with the neurological disease, TSP/HAM 
(tra~'tca'~ spas~'tc parapare~:~s~'tt"i'L~-'~ as oc'~a~e0 mye'~opa~hy'~. "The~L",?-'~ .geaome encodes a pro't~n, "Ia~¢, that team" ae6va~es v'~ra'~ and ce'~'tu'~ar 
ha ~lial cells which carried the Tax-expressing vector. We demonztrated that Tax expre~iot~ enhanced the prodqction b), ~l al cells of interleukin 
(I L)-1, It-6, granulocytc-macrophag¢ colony-~timulatina factor (GM-CSF)and transforming growth factor (TGF)fl. We suggest that the excessive 
production of cytokines in nervous tissue ma:t play a role in pathogenesi~ of TSP/HAM. Glial cells that carry the tax l~en¢ may provide a modal 
a~el'ul for in vitro study of the mechanism of production of cytokines in the nervous system. 
Glial cell; HTLV-k tax; Cytokine; Gene activation 
I. INTRODUCTION 
Human T-cell lymphotropie virus type I (HTLV-1) 
has been identified as the infectious agent responsible 
for adult T-cell leukemia [1,2]. Its genome encodes a 
40-kDa nuclear protein (.Tax) [3] which is associated 
with the leukomogenesis of this disorder. Tax is a potent 
trans activator both o[' the transcription directed by the 
viral long terminal repeat, and o f  the transcription of 
~ci f i¢  cellular ~enes such a~ ~umor necrosis factor 
(TNF)  ~x [4], granulocyte-maerophage colony-stimulat- 
ing factor (GM-CSF)  [5]° interleukin ( I t )  -2 [6,7], I t -3  
[8], and I t -2  receptor [6,7,9]. HTLV- i  is also associated 
with a neurological disorder ~uch as i.ropical spastic 
paraparesis Ci'SP), also ca'fled WI'L'¢-I associa'~ed mye- 
lopathy (,HAM) [t0,l t]. Recentty~ we demonstrated that 
introduction of tax gene into glial cells caused expres- 
sLon of tM major tdstocompatLbili.ty complex (MHC)  
class I antigen [12], a key molecule involved in ira, 
munorecogniti0n. Therefore° it is possible that Tax may 
produce some phenotypieal changes in the neural cell~ 
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TNF, tumor necrosis factor; TPA, 12-O-tetradeeanoylphorbol-I 3-ac- 
etate; TSP, trol~ical spastic parapare~is. 
of  TSP /HAM patients. Neural ¢~lls can produce and/or 
respond to a variety ofeytokines which function as both 
neuro- and immunomodulators [13]. It has been sug. 
ge~ted that those ¢ytokines may play an important role 
in the pathogenesi~ of  TSP/HAM,  since elevated levels 
of  IL-6 have been demonstrated in serum and cerebro- 
spinal fluid of  HAM patients [14]. Here, we show the 
effect of  Tax on cytokine production in glial cells by tax 
gene tranffeetion. 
2. MATERIALS  AND METHODS 
2.'1. ~lasmT(l 
p~l"CX'ffb wa~ usea' as an cxpr~z~ba vector o1" i'hx (g,~. i'd~ 
plazmid ¢ontain~ llle mouse metallothionein promoter as an inducible 
9ro~ter. 
2.-'2-. Cell ca#are and lransfeclion 
C6 rat glial ceils were cultured at 37°C in Falcon plastic culture 
dishc~ (Becton Dickinson, Lincoln Park, NJ) with Eagle's minimal 
essential medium containing 10% fetal bovine serum (Gibco BRL. 
Gaithersburg, MD). One million cells were trannfcctcd with 2,~8 of 
pMTCXdb and 0,$/~8 of pSV2Neo by the Shimadzu Somatic Hy- 
bridizer I (Shimadzu, Kyoto, Japan). Alter cultivation f r 48 h in that 
medium, the c¢11.~ were treated with the m~ium supplemented with 
800 Itg of G418 (Gibco BRL) and/~rown for two weeks under contin- 
uous G418 ~leclion. More than 100 G418-resislant colonies were 
pooled, propagated an  u~d aa ta.,t-¢xprezsin8 cells, C6px. C6px were 
treat~ with or witluaut lipopolysaccharide (LPS), 12-O-tetrade- 
canoylphorbol-13-acetate (TP-~) and ZnSO~ for 12 h. Supernatani 
fraclions were collected for measurement of cytokine contents. Cells 
were washed twi~ with phosphate.buffered saline and u~ed for RNA 
preparation. 
2.3. RNA preparation and RT-PCR 
Total RNA was isolated by the method fChom~ynnki and Saeehi 
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Fis. 1. mRNA expression of tax and cytokines in C6 (lar~c 1--4) and C6px (lane 5-8) cells. PeR produet~ of tax (A), IL-6 (B), IL-I (C), TNF 
(D) and TGF,6 (E) derived from cells treated with 100 n~ml of LPS {lanes 2 and 6), 100 ng/ml of 'rPA (lanes 3 and 7), ~0/~M of ZnSO.~ (lanes 
4 and t0, or medium (hme 1 and 5) for 12 h were indicat~xl. (A) 2% agarose gel eleetrophorcsis, {B-E); 8-25% polyacrylamide g l electrophoresis, 
[15], An amount of 1 /.tB of RNA was used for first-strand eDNA 
synthesis at 37°C For 90 rain with 50 units of r~.~omblnmlt M-MuLV 
reverse trunscriptase (Boehrinser.Mannheim, Mannheim, Germany) 
and 0.2/ag of DNA random hexamers. The reaction was terminated 
by boilinE for 5 rain, and 2/,tl of the mixture was amplified by 30 PCR 
cycles with 0.5 units of" taq polymerase (Promega, Madison. WI) and 
0.5 ltg each of the sen~ and antisanse primers, Th~ thermal cycle 
profile was as Follows: 1 min at 94°C, 1 rain at 55°C, and 2 rain ~tt 
72¢C. An aliquot (5 al) of the PCR mixture was subjt.,ct~l to electro- 
phoresis in 2% ap, arose sel or 8-25% polyucrylamlde 8 l in TBE buffer, 
The agarose 8el wa.~ then stained with ethidium bromide and photo- 
8raphed. Polyacrylamide gel was tained by the ~tandard silver stain- 
ing method, The PCR products were ident;%d by the size which were 
predicted from the sequence {described in section 2.4). 
2.4, Primers for PCR 
The following primers were used Ibr gene amplification; tax sense, 
5'CCCACTTCCCAGGGTTTGGACGAG; tax anti-sense, 5'CFGT. 
AGAGCTGAGCCGATAACGCG~ IL-I,8 sense, 5'-GAAGCTGTG- 
GCAGCTACCTATGTCT; ! L- 1/5 anti~ense, 5'-CTCTGCTTGAGA- 
GGTGCTGATGTAC; IL.6 sense, 5"-GACTGATGTTGTTGACA- 
GCCACTGC; IL-6 anti-sense, 5'.TAGCCACTCCTTCTGTGACT- 
CTAACT; TNF ~x sense, 5'.CACCACGCFI'CTTCTGTCTACTGAA- 
C; TNF ~x anti.sense, 5 ' .CCGGACTGCGTGATGTCTAAGTACT;  
TGF fl sense, 5'.c'rccCACTCCCOTGGCTTCTAG; and TGF ,8 
anti-sense, 5'-GTTCCACATGTTGCTCCACATrG, The sizes of 
PCR products for tax, IL-I/5, IL-6, TNF or, and TGF/5 were 203 bp, 
520 bp, 509 bp, 546 bp, and 472 bp, reslxetively, 
Table 1 
Cytokine activity in medittm of C6 and C6px ¢¢11s 
Treatment IL-I activity IL-6 activity GM-CSF activity 
(mU/ml) (U/ml) (Ulml) 
C6 C6px C6 C6px C6 C6px 
Medium 0 14 I o 620 0 0.46 
ZnSO., (80 M) 0 15 31 1490 ND ND 
TPA (0.1 tudml) 6 280 67 2350 ND ND 
LPS (0.1 bt~/ml) 6 50 48 1930 0.28 0.60 
One million cells wer ,~ seeded in 10.cm diameter plastic dishes with 10 ml medium and treated its indicated tbr 12 h. ND = not determined. IL-I, 
interleukin- 1;IL-6, interleukin-6; GM-CSF, sranutocyte-macrophage ¢dony-5timulating factor: TPA, 12-O-tetr,'tdecanoylphorbol- 13-acetate; LPS, 
lipopolysaccharide. Values indicate tile mean of two independent experiments of each measurement carried out in triplicate. SD values were le~s 
than 10% of thc mean, 
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FI~. 2. (A) Time-dependent expression of tax (upper) and IL.6 (lower) mRNA in C6 (lan¢~ 1-5) and C6px (lanes 6-10) cells at 0 (lanes 1 and 6), 
in IL-6 activity in the sapernatant ofC6 (left) and Cdpx (right) alter LPS stimulation. Columns indicate the mean of two independent e~periments 
of each measurement carried out in triplicate SD values were less than 10% of the mean. 
2,5, Cytokine assays 
Activities of IL-1, IL-6 and GM.CSF were determined by bioassay 
tt~in$ D10 cells (from Dr, K. Onozaki. Nagoya City University) [16], 
MHd0 (from Dr, T, Hirano, Omka Univer-.ity, Japan) [17] cells and 
was measured by colorimetrie assay de~rib~ previously [19]. 
3. RESULTS 
Cdp×, the pMTCXdb-transfected cells, expressed tax 
was enhanced by agents that stimulated the metal- 
lothionein promoter such as LPS, TPA, and ZnSO~ 
(Fig. I A). Expression of tax mRNA was accompanied 
by that tbr IL-I, 1L-6 and TGFfl (Fig. I B, C and E). 
Expression of IL-6 mRNA in C6px further increased, 
following stimulation of metallothionein promoter with 
LPS, TPA~ and ZnSO4 (Fig. lB). Expression of IL-i 
(Fig. lC, lane 7). Expression of TGFFl was observed in
C6px but not in C6 cells (Fig. l E). Production ofcytok- 
inc activities was also enhanced by tax.transfection 
(Table I). C6px increased the activity of 1L-6 by 62-fold 
as compared with parental C6 cells. The activity of IL-I 
e,~, G~A-CSF ,,~,,~ detected i.n C69x. Further enh~tace- 
ment oflL-I, IL-6, and GM-CSF activity was observed 
in Cdpx treated with ZnSO4, TFA and/or LPS. ~"~:'~'"-,~,,,,. 
TNF~ mRNA (Fig. ID) nor TNFa activity were de- 
tected. 
49 
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To investigate the r lationship between Tax expres- 
siotl and the enhancement of cellular promoters, we 
examined the time-dependent change of IL-6 mRNA 
and the biological activity in C6 and C6px following 
LPS treatment. The tax mRNA expression i  C6p:,, in- 
creased at 30 mi,1 and peaked at 60 mix after LPS 
treatment (Fig. 2A). IL-6 mRNA expression in C6px 
increased at 6 h after LPS treatrnent (Fig. 2A). IL-6 
activity in C6px also increased at 6 h after LPS treat- 
metat, although that in parental C6 cells increased grad- 
ually from 60 rain to 6 h (Fig. 2B). 
4. DISCUSSION 
This study of C6px, the gliai cells that carry the 
HTLV-I tax gone, demonstrates that Tax stimulated the 
production of IL-i, IL-6, GM-CSF and TGFFl in cells 
derived from nervous tissues. This was supported by the 
following lines of evidence in the case of IL-6: (i) trans- 
fection of tax.expression vector to C6 cells enhanced 
both mRNA and biological activity of IL-6 (Fig. i and 
Table 1): (it) stimulation of metallothionein promoter 
increased IL-6 production in C6px (Fig. 1 and Table 1); 
and (iii) the enhancement of IL-6 production in LPS- 
stimulated C6px was slower than that in parental C6 
cells (Fig. 2). This suggests that tax mRNA may be 
translated into Tax, followed by the induction of IL-6 
mRNA in C6px by a trans activation of IL-6 gone by 
Tax. Thi~ is the first study to demonstrate hat Tax 
induces the production of eytokines in neural cells, al- 
though similar phenomena have been demonstrated in 
T-cells arLd fibroblasts [8]. While TNF has also been 
demonstrated to be overproduced in T-cells of patients 
with HTLV-I [4], we could not detect either the mRNA 
(Fig. ID) or the biological activity ofTN F~x. We did not 
find that C6px express either IL-2 or IL-2 receptor (data 
not shown), which are known to be expressed in T-cells 
carrying tax [6,7,9]. Therefore, it is possible that differ- 
ent mechanisms may control gone expression of some 
cytokiaes, but not all, in the neural cells :~nd T-cells. 
Moreover, since each cytokine xpression i neural cells 
by tax transfection with or without, stimulants showed 
different patterns, it may be regulated in a different 
manner. Further investigations of cytokines in neural 
co!!:; are necessary for understanding that. 
It was recently reported that Tax enhanced the tran- 
scription of proenkephalin mRNA in glial cells [20]; 
enkephalin, a neuropeptide, influences the immtme sys- 
tem. Similarly, cytokines contribute to neuro-immune 
~ystem communications, but more directly than does 
eakephalin. As reported previously, glial cells produce 
a variety of cytokines which regulate both the nervous 
and the iramune systems [13]. When Tax enflanced cy- 
eases, it causes pertttrbation of the eytokine network in 
both the immune and nervous systems. We also re- 
ported that tax.transfected glial cells were induced to 
express the M HC class I molecule [12], which is impor- 
tant in recognition by T-cells. Such changes in Tax- 
expressing neural cells may be involved in the patho- 
genesis of HTLV-l-asscciated neurological disease. The 
pathological role of trans activation by Tax awaits fur- 
thor clarification. 
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